Cognition Therapeutics, Inc. Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security
Cognition Therapeutics, Inc. (CGTX) reported Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security of $4.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities · last filed 2022-03-30
- Cognition Therapeutics, Inc. repayment of long-term debt, long-term lease obligation, and capital security for the quarter ending 2020-12-31 was $0.00.
- Cognition Therapeutics, Inc. repayment of long-term debt, long-term lease obligation, and capital security for fiscal 2020 was $4.00K.
| Period end | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 3 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 9 month | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $4.00K 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |